Page last updated: 2024-10-16

carbamates and Laryngopharyngeal Reflux

carbamates has been researched along with Laryngopharyngeal Reflux in 1 studies

Laryngopharyngeal Reflux: Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.

Research Excerpts

ExcerptRelevanceReference
" A mouse model of laryngopharyngeal reflux (mechanical laryngeal injury once weekly for 2 weeks and pH 7 solvent/pepsin instillation 3 days/week for 4 weeks) was provided inhibitor by gavage or aerosol (fosamprenavir or darunavir; 5 days/week for 4 weeks; n = 3)."8.31Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model. ( Arnold, LA; Blumin, JH; Bock, J; Goetz, CJ; Johnston, N; MacKinnon, AC; Miller, J; Ondrey, F; Samuels, TL; Seabloom, D; Silvaggi, NR; Smith, BC; Vuksanovic, N; Wiedmann, TS; Wuertz, B, 2023)
" A mouse model of laryngopharyngeal reflux (mechanical laryngeal injury once weekly for 2 weeks and pH 7 solvent/pepsin instillation 3 days/week for 4 weeks) was provided inhibitor by gavage or aerosol (fosamprenavir or darunavir; 5 days/week for 4 weeks; n = 3)."4.31Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model. ( Arnold, LA; Blumin, JH; Bock, J; Goetz, CJ; Johnston, N; MacKinnon, AC; Miller, J; Ondrey, F; Samuels, TL; Seabloom, D; Silvaggi, NR; Smith, BC; Vuksanovic, N; Wiedmann, TS; Wuertz, B, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Johnston, N1
Samuels, TL1
Goetz, CJ1
Arnold, LA1
Smith, BC1
Seabloom, D1
Wuertz, B1
Ondrey, F1
Wiedmann, TS1
Vuksanovic, N1
Silvaggi, NR1
MacKinnon, AC1
Miller, J1
Bock, J1
Blumin, JH1

Other Studies

1 other study available for carbamates and Laryngopharyngeal Reflux

ArticleYear
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model.
    The Laryngoscope, 2023, Volume: 133 Suppl 1

    Topics: Animals; Carbamates; Furans; Laryngopharyngeal Reflux; Larynx; Mice; Pepsin A; Sulfonamides

2023